Meta AnalysisID 87

巴西药用植物治疗骨关节炎有效性与安全性的系统评价与Meta分析:研究方案

CRD42015019793

What is the efficacy and safety of herbal drugs sold in Brazil for the treatment of osteoarthritis?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Herb: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
87
Evidence Id
8645
Core Evidence Id
8645
Source Meta Analysis Id
79
Herb2 Meta Analysis Id
HBMA000079
Crd Id
CRD42015019793
Title
Systematic review and meta-analyses of effectiveness and safety of Brazilian medicinal plants in the treatment of osteoarthritis: study protocol
Review Question
What is the efficacy and safety of herbal drugs sold in Brazil for the treatment of osteoarthritis?
Study Type Included
Randomized controlled trials including an arm in which patients received one of the 13 herbal medicines listed below compared to an arm in which patients receive an inert (placebo) or an active non-herbal medicine control.
Condition Being Studied
Osteoarthritis affects 1% of world population and is the most common cause of musculoskeletal impairment in the elderly, becoming a major challenge to health systems. It was found that some medicinal plants are effective for this condition, however, there were no systematic reviews investigating the effects of medicinal plants used in Brazil for the treatment of pain due to osteoarthritis.
Participant
Patients: Studies must include adults (>18 years old) with osteoarthritis diagnosis according to the criteria of American College of Rheumatology (ACR) (ALTMAN, 1991) or the equivalent criterion of European League Against Rheumatism (EULAR): lequesne index (ZHANG, 2010).
Animal
Human Disease Modelled
Intervention
Studies must include an arm in which patients are taking one of the 13 herbal medicines used by the Brazilian population from any of the following plant preparations (whole, powder, extract, standardised mixture) with one of the select plants: Harpagophytum procumbens DC. ex Meisn., Uncaria tomentosa (Willd.) DC., Boswellia serrata Roxb. ex Colebr., Bowdichia virgilioides Kunth., Curcuma longa L. (or Curcuma domestica Valeton), Chenopodium ambrosioides L., Cordia curassavica (Jacq.) Roem. & Schult. (or Cordia verbenacea DC.), Salix alba L., Salix daphnoides Vill, Salix purpurea L., Persea gratissima Gaertn.f. (or Persea americana Mill.), Uncaria guianesis (Aubl.) J.F. Gmel and Zingiber officinale Roscoe. Studies that associated the use of the plant with homeopathy, aromatherapy, or preparation of synthetic origin; and studies that investigated the simultaneous use of more than one of the eligible plants will be excluded.
Comparator Control
Studies in which patients are compared to a control group (patients receive placebo or a non-herbal medicine controls, for example, a nonsteroidal anti-inflammatory drug - NSAID).
Main Outcome
Our outcomes will be consistent with those proposed by the Cochrane Musculoskeletal Group systematic intervention reviews for osteoarthritis (ALTMAN, 1996; PHAM, 2004). Primary outcomes: •
Outcome Measure
Additional Outcome
Study Method
Systematic review
Keyword
Brazil; Humans; Osteoarthritis; Osteoarthritis, Knee; Plants, Medicinal; Safety
Contact
Organisational Affiliation
Funding Source
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Review Stage
First Submission Date
Registration Date
Anticipated Start Date
Anticipated Completion Date
Title Cn
巴西药用植物治疗骨关节炎有效性与安全性的系统评价与Meta分析:研究方案
Title En
Systematic review and meta-analyses of effectiveness and safety of Brazilian medicinal plants in the treatment of osteoarthritis: study protocol
Bilingual Status
complete